<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="/xsl/rss2.xsl"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title>ViiV Healthcare Company et al v. Aurobindo Pharma Ltd. et al :: Justia Dockets &amp; Filings</title>
        <link>https://dockets.justia.com/docket/delaware/dedce/1:2025cv01331/91035</link>
        <atom:link href="https://dockets.justia.com/docket/delaware/dedce/1:2025cv01331/91035/feed" rel="self" type="application/rss+xml" />
        <pubDate>Wed, 17 Jun 2026 02:03:13 -0700</pubDate>
        <lastBuildDate>Wed, 17 Jun 2026 02:03:13 -0700</lastBuildDate>
        <generator>Justia Dockets &amp; Filings</generator>
        <copyright>Copyright 2026 Justia Inc</copyright>
        <description>ViiV Healthcare Company et al v. Aurobindo Pharma Ltd. et al - Docket Entries - Showing 1 through 20</description>
                                    <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re #20 STIPULATION TO EXTEND TIME the deadline for the Parties to submit a Proposed Scheduling Order to May 22, 2026 filed by ViiV Healthcare UK (No.3) Limited, ViiV Healthcare Company, Shionogi & Co., Ltd. Signed by Judge Gregory B. Williams on 4/23/2026. (lnb)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_34412048</guid>
                <pubDate>
            Thu, 23 Apr 2026 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 20]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION TO EXTEND TIME the deadline for the Parties to submit a Proposed Scheduling Order to May 22, 2026 - filed by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No.3) Limited. (Joyce, Alexandra)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_34412049</guid>
                <pubDate>
            Wed, 22 Apr 2026 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 19]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE of Withdrawal of Daniel J. Ritterbeck by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. (Dorsney, Kenneth)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_34412051</guid>
                <pubDate>
            Fri, 10 Apr 2026 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                Remark --Terminated Attorney Daniel J. Ritterbeck due to D.I. 19 (lnb)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_34412050</guid>
                <pubDate>
            Fri, 10 Apr 2026 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re #18 STIPULATION TO EXTEND TIME for the Parties to submit a Proposed Scheduling Order to April 22, 2026 filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd. Signed by Judge Gregory B. Williams on 3/24/2026. (jaa)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_34412052</guid>
                <pubDate>
            Tue, 24 Mar 2026 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 18]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION TO EXTEND TIME for the Parties to submit a Proposed Scheduling Order to April 22, 2026 - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Hitch, Cortlan)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_34412053</guid>
                <pubDate>
            Mon, 23 Mar 2026 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re #17 STIPULATION TO EXTEND TIME for the parties to file a Proposed Scheduling Order to March 23, 2026 filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd. Signed by Judge Gregory B. Williams on 2/18/2026. (lnb)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_34412054</guid>
                <pubDate>
            Wed, 18 Feb 2026 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 17]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION TO EXTEND TIME for the parties to file a Proposed Scheduling Order to March 23, 2026 - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_34412055</guid>
                <pubDate>
            Tue, 17 Feb 2026 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 16]]>
                    </title>
                <description>
            <![CDATA[
                ANSWER to #13 Answer to Complaint, Counterclaim by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No.3) Limited.(Silver, Daniel)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_34412056</guid>
                <pubDate>
            Tue, 20 Jan 2026 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 15]]>
                    </title>
                <description>
            <![CDATA[
                ORAL ORDER: IT IS HEREBY ORDERED that, by no later than February 20, 2026, the parties shall meet and confer and file a joint proposed Scheduling Order in this action consistent with the applicable form Scheduling Order of Judge Williams, which is posted at http://www/ded/uscourts.gov (See Chambers, Judge Williams, Forms), along with a cover letter requesting the Court to enter the joint proposed Scheduling Order (if there are no disputes or other issues concerning scheduling that the Court needs to address) or to schedule the Scheduling Conference. If there are disputes or other issues the Court needs to address in the joint proposed Scheduling Order, in the cover letter, the parties shall direct the Court to the paragraph numbers in the joint proposed Scheduling Order which those appear. ORDERED by Judge Gregory B. Williams on 1/20/2026. (lnb)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_34412057</guid>
                <pubDate>
            Tue, 20 Jan 2026 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                Pro Hac Vice Attorney Daniel J. Ritterbeck, Dennies Varughese & Ryan N. Kaiser for Aurobindo Pharma Ltd. & Aurobindo Pharma USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (slk)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_34412058</guid>
                <pubDate>
            Thu, 08 Jan 2026 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re #11 MOTION for Pro Hac Vice Appearance of Attorney Ryan N. Kaiser, Attorney Daniel J. Ritterbeck, and Attorney Dennies Varughese filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd.. Signed by Judge Gregory B. Williams on 1/2/26. (jaa)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_34412059</guid>
                <pubDate>
            Fri, 02 Jan 2026 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 14]]>
                    </title>
                <description>
            <![CDATA[
                Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma Limited for Aurobindo Pharma USA, Inc. filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Hitch, Cortlan)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_34412060</guid>
                <pubDate>
            Mon, 29 Dec 2025 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 13]]>
                    </title>
                <description>
            <![CDATA[
                ANSWER to #1 Complaint, Affirmative Defenses and, COUNTERCLAIM against All Plaintiffs by Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd..(Hitch, Cortlan)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_34412061</guid>
                <pubDate>
            Mon, 29 Dec 2025 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 12]]>
                    </title>
                <description>
            <![CDATA[
                Pro Hac Vice Fee - Credit Card Payment received for Ryan N. Kaiser, Daniel J. Ritterbeck, and Dennies Varughese. ( re #11 MOTION for Pro Hac Vice Appearance of Attorney Ryan N. Kaiser, Attorney Daniel J. Ritterbeck, and Attorney Dennies Varughese )( Payment of $ 150, receipt number ADEDC-4866398).(Hitch, Cortlan)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_34412062</guid>
                <pubDate>
            Mon, 29 Dec 2025 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 11]]>
                    </title>
                <description>
            <![CDATA[
                MOTION for Pro Hac Vice Appearance of Attorney Ryan N. Kaiser, Attorney Daniel J. Ritterbeck, and Attorney Dennies Varughese - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Hitch, Cortlan)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_34412063</guid>
                <pubDate>
            Mon, 29 Dec 2025 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re #10 STIPULATION TO EXTEND TIME for Aurobindo to Answer, Move or Otherwise respond to the Complaint to December 29, 2025 filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd., Set/Reset Answer Deadlines: All Defendants. Signed by Judge Gregory B. Williams on 12/12/2025. (lnb)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_32152254</guid>
                <pubDate>
            Fri, 12 Dec 2025 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 10]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION TO EXTEND TIME for Aurobindo to Answer, Move or Otherwise respond to the Complaint to December 29, 2025 - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Hitch, Cortlan)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_32152255</guid>
                <pubDate>
            Thu, 11 Dec 2025 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 9]]>
                    </title>
                <description>
            <![CDATA[
                DECLARATION of Service for Aurobindo Pharma Ltd. by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No.3) Limited. (Attachments: #1 Exhibit A-B)(Joyce, Alexandra)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_32152256</guid>
                <pubDate>
            Tue, 25 Nov 2025 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 8]]>
                    </title>
                <description>
            <![CDATA[
                SUMMONS Returned Executed by ViiV Healthcare Company, Shionogi & Co., Ltd., ViiV Healthcare UK (No.3) Limited.Aurobindo Pharma USA, Inc. served on 11/24/2025, answer due 12/15/2025. (Silver, Daniel)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_32152257</guid>
                <pubDate>
            Tue, 25 Nov 2025 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 7]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE of Supplemental Rule 7.1 Disclosure Statement for Plaintiffs ViiV Healthcare Company and ViiV Healthcare UK (No. 3) Limited by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No.3) Limited (Silver, Daniel)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_32152258</guid>
                <pubDate>
            Thu, 13 Nov 2025 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (alb)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_32152259</guid>
                <pubDate>
            Wed, 05 Nov 2025 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 6]]>
                    </title>
                <description>
            <![CDATA[
                Summons Issued as to Aurobindo Pharma Ltd. on 10/31/2025; Aurobindo Pharma USA, Inc. on 10/31/2025. (Attachments: #1 Summons Issued)(oam)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_31058571</guid>
                <pubDate>
            Fri, 31 Oct 2025 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 5]]>
                    </title>
                <description>
            <![CDATA[
                Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent ViiV Healthcare Company, Corporate Parent Viiv Healthcare UK Limited, Other Affiliate GSK plc, Other Affiliate GlaxoSmithKline Mercury Limited, Other Affiliate PHIVCO Luxembourg Sarl, Other Affiliate PHIVCO Corp, Other Affiliate Shionogi B.V., Other Affiliate ViiV Healthcare Limited. for ViiV Healthcare UK (No.3) Limited; Corporate Parent ViiV Healthcare Limited, Other Affiliate GSK plc, Other Affiliate GlaxoSmithKline Mercury Limited, Other Affiliate PHIVCO Luxembourg Sarl, Other Affiliate PHIVCO Corp, Other Affiliate Shionogi B.V., Other Affiliate ViiV Healthcare Limited. for ViiV Healthcare Company filed by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No.3) Limited.No Parents or Affiliates Listed for Shionogi & Co., Ltd. filed by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No.3) Limited. (Attachments: #1 7.1 Disclosure)(oam)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_31058572</guid>
                <pubDate>
            Thu, 30 Oct 2025 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 4]]>
                    </title>
                <description>
            <![CDATA[
                Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,242,986. (oam)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_31058573</guid>
                <pubDate>
            Thu, 30 Oct 2025 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 3]]>
                    </title>
                <description>
            <![CDATA[
                Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 09/18/2025. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 3/18/2028. (oam)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_31058574</guid>
                <pubDate>
            Thu, 30 Oct 2025 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 2]]>
                    </title>
                <description>
            <![CDATA[
                Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (oam)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_31058575</guid>
                <pubDate>
            Thu, 30 Oct 2025 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 1]]>
                    </title>
                <description>
            <![CDATA[
                COMPLAINT for PATENT INFRINGEMENT filed against Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. ( Filing fee $ 405, receipt number ADEDC-4826292.) - filed by ViiV Healthcare Company, Shionogi & Co., Ltd., ViiV Healthcare UK (No.3) Limited. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(oam)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_31058576</guid>
                <pubDate>
            Thu, 30 Oct 2025 00:00:00 -0700
        </pubDate>
    </item>
                </channel>
</rss>
